Expanding the power of drugs used to treat liquid malignancies into solid tumours. We screened an epigenetic compound library against cell lines models of ovarian clear cell carcinoma. The BTK inhibitor ibrutinib shows promise #ovariancancer #ibrutinib 🧪 onlinelibrary.wiley.com/doi/epdf/10....

Real-World Data Confirm Safety of Ibrutinib Dose Modifications in CLL Early dose modifications to ibrutinib in CLL are primarily driven by comorbidity and functional status and may not compromise survival.

Early dose modifications to #Ibrutinib in chronic lymphocytic leukemia (#CLL) are primarily driven by patient comorbidity and functional status rather than disease biology, and do not independently compromise survival outcomes.

Read more: https://bit.ly/4vb9sDE

#Oncology #MedSky

#CLL cells accumulate lipid peroxides & iron, predisposing them to #ferroptosis; #BTK inhibition raises #TFRC and sensitizes cells, while combining #ibrutinib with #GPX4 blockade enhances efficacy, with TFRC and #ACSL1 emerging as targets.

#OpenAccess #STTT: doi.org/10.1038/s413...

CREB1 activates GPX4 transcription & inhibits #Ferroptosis, promoting #GastricCancer cell proliferation and decreasing platinum sensitivity, while, #Ibrutinib suppresses GC progression via the EGFR–PI3K–AKT–CREB1 axis.

#OpenAccess: doi.org/10.1016/j.ge...

Researchers reveal #ferroptosis as a targetable vulnerability in #ChronicLymphocyticLeukemia, showing that BTK inhibition increases iron uptake via TFRC, and combining #ibrutinib with #GPX4 or ACSL1 targeting enhances ferroptosis.

#OpenAccess in #STTT: doi.org/10.1038/s413...

#ASH25 In the first head-to-head study of the two drugs, #pirtobrutinib was found to produce ORRs that were noninferior to those seen with #ibrutinib in both the intent-to-treat and R/R population of patients with #CLL: https://ow.ly/WIEg50XExWA
#HemeSky #OncSky

Individualized Therapy Associated With Greater Rates of Undetectable MRD, Extended PFS in CLL | ASH Clinical News | American Society of Hematology

In patients with treatment-naïve #CLL, MRD-guided therapy with #ibrutinib plus #venetoclax led to greater rates of undetectable MRD, extended PFS, and increased OS than ibrutinib alone or #chemoimmunotherapy, especially among patients with unmutated IGHV: ow.ly/oA2u50WWZZc #HemeSky #HemeOnc

Lilly’s Jaypirca shows positive results in phase 3 trial - PharmaTimes Pirtobrutinib meets primary endpoint in CLL/SLL study

#oncology #Lilly #LillyOncology #Jaypirca #Pirtobrutinib #primaryendpoint #EliLilly #CLL313 #CLL314 #phase3 #BRUINCLL314trial #chroniclymphocyticleukaemia #CLL #smalllymphocyticlymphoma #SLL #noncovalentBTKinhibitor #Imbruvica #ibrutinib #covalentBTKinhibitor
pharmatimes.com/news/lillys-...

Ibruxen 140 mg (Ibrutinib) | Online International Pharmacy Ibruxen 140 mg (Ibrutinib) is a targeted therapy used to treat certain blood cancers by inhibiting Bruton's tyrosine kinase.

Ibruxen 140 mg (Ibrutinib) is an oral medication used to treat blood cancers like chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström’s by inhibiting Bruton's tyrosine kinase (BTK).
#Ibruxen140mg #Ibrutinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/ibru...

Optimizing CLL/SLL Therapy: Pirtobrutinib Matches Ibrutinib in Phase 3 Pirtobrutinib shows promising results in treating CLL, outperforming ibrutinib in a pivotal phase 3 trial, paving the way for broader applications.

Le #Pirtobbrutinib donne des résultats prometteurs dans le traitement de la #LLC 🩸, surpassant l’ #Ibrutinib dans un essai pivot de phase 3, ouvrant la voie à des applications plus larges.
www.targetedonc.com/view/optimiz...

Synapse: Your Connection to our MSK Authors
Meet: Anna F Piotrowski
Research Focus: Neurology; Assistant Attending

synapse.mskcc.org/synapse/work...

#Ibrutinib #CNSLymphoma #TargetedTherapy #PhaseIITrial #BloodCancer #OncologyUpdates #CancerTreatment #ClinicalTrials #CancerResearch

Vincent Rajkumar: Incredible Story of How Ibrutinib Came About in CLL by Jeff Sharman - OncoDaily Vincent Rajkumar shares Jeff Sharman’s thread detailing the origins of BTK inhibitor ibrutinib in treating CLL.

Incredible Story of How Ibrutinib Came About in CLL by Jeff Sharman - Vincent Rajkumar
@vincentrk.bsky.social

oncodaily.com/insight/ibru...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Ibrutinib #CLL #BTKInhibitors #Leukemia #Hematology

Featured today by @MSKLibrary: Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis

#Ibrutinib #Hematology #TransplantMedicine #RealWorldData #OncologyResearch #MedicalAdvancements #BoneMarrowTransplant

dx.doi.org/10.1182/bloo...

Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk Epstein-Barr virus (EBV)-encoded nuclear antigen, EBNA2, expressed in EBV-infected B lymphocytes is critical for lymphoblastoid cell growth. Microarray profiling and cytokine array screening revealed ...

Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk #EBV #ibrutinib #MECFS #LongCovid

pmc.ncbi.nlm.nih.gov/articles/PMC...

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton’s Tyrosine Kinase #ibrutinib #MECFS #LongCovid

bsky.app/profile/rene...

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology #ibrutinib #MECFS #LongCovid

bsky.app/profile/rene...

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology #ibrutinib #MECFS #LongCovid

www.linkos.cz/files/klinic...

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively - Journal of Experimental & Clinical Cancer Research Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by uncontrolled proliferation of B-cells and severe immune dysfunction. Chemo(immuno)therapies (CIT) have traditionally a...

jeccr.biomedcentral.com/articles/10....

#Ibrutinib "also shifts the equilibrium of CD4+ T-cells from Th2 and Th17 cells to a Th1 environment by inhibiting ITK, reverses CD8+ cell exhaustion and favors activation of CD8+ cytotoxic T-cells"

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively - Journal of Experimental & Clinical Cancer Research Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by uncontrolled proliferation of B-cells and severe immune dysfunction. Chemo(immuno)therapies (CIT) have traditionally a...

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively #Ibrutinib #MECFS #LongCovid

jeccr.biomedcentral.com/articles/10....

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton’s Tyrosine Kinase #ibrutinib #MECFS #LongCovid

bsky.app/profile/rene...

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton’s Tyrosine Kinase High platelet reactivity leading to spontaneous platelet aggregation (SPA) is a hallmark of cardiovascular diseases; however, the mechanism underlying SPA remains obscure. Platelet aggregation in stir...

Spontaneous Platelet Aggregation in Blood Is Mediated by FcγRIIA Stimulation of Bruton’s Tyrosine Kinase #ibrutinib #MECFS #LongCovid

www.mdpi.com/1422-0067/23...

Multiomics Integration Elucidates Metabolic Modulators of Drug Resistance in Lymphoma Background Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL). B-cell NHLs rely on Bruton’s tyrosine kinase (BTK) mediated B-cell receptor signaling for survival and d...

www.biorxiv.org/content/10.1...

#Ibrutinib, "a selective and irreversible BTK inhibitor, has been successfully utilized in various leukemia and lymphoma models."

New blood-clotting disorder identified Researchers at McMaster University have made a discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

medicalxpress.com/news/2025-02...

"but they showed some benefit with unusual treatments, such as high-dose intravenous immunoglobulin ( #IVIG), Bruton tyrosine kinase inhibitors ( #ibrutinib), and plasma cell–targeted myeloma therapy."

Ibrutinib: Todo lo que Necesitas Saber sobre su Uso, Beneficios y Efectos Secundarios ¿Qué es el Ibrutinib y cómo funciona en el tratamiento del cáncer? El ibrutinib es un fármaco de la clase de los inhibidores de la tirosina quinasa que se utiliza principalmente en el tratamiento... The post Ibrutinib: Todo lo que Necesitas Saber sobre…

Ibrutinib: Todo lo que Necesitas Saber sobre su Uso, Beneficios y Efectos Secundarios #Ibrutinib #Cáncer #Salud

A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma Background/Objectives: Aurora (AK) A/B are oncogenic mitotic kinases that when over-expressed are poor prognostic markers in mantle cell lymphoma (MCL). Methods and Results: Alisertib, an AK-A inhibit...

Overcoming #Ibrutinib resistance in #MCL with #alisertib
www.mdpi.com/3098756

Ibrutix 140 mg (Ibrutinib) | Buy Generic Medicine IEB PHARMA This Ibrutix 140 mg (Ibrutinib) is only for people who have already had at least one prior therapy. People with Mantle cell are told to take this medicine.

Ibrutinib is a small-molecule inhibitor of BTK. Ibrutinib forms a covalent bond with a cysteine residue in the BTK active site, leading to inhibition of BTK enzymatic activity.
#Ibrutix140mg #Ibrutinib #IebPharma #AntiCancer #AntiViral #BreastCancer
iebpharma.com/product/ibru...

Lovely catching up with Carsten Niemann on the GLOW study 64-month follow-up: #ibrutinib + #venetoclax outperforms #chlorambucil + #obinutuzumab in elderly/comorbid patients 🩸🔦

Stay tuned for the full video www.vjhemonc.com/event/ash-20... 👀

@ash-hematology.bsky.social #ASH24 #CLL

Prior to the transplant, high doses of chemotherapy are administered to destroy as many myeloma cells as possible. Then, healthy stem cells.
#Ibrutix140mg #Ibrutinib #Medicine #Health #OnlineMedicine #MedicineStore #AntiCancer #LiverCancer
iebpharma.com/product/ibru...

Targeted therapy: This form of treatment targets specific weaknesses present within the cancer cells. Biological therapy: These drugs use.
#Ibruxen140mg #Ibrutinib #Medicine #Health #OnlineMedicine #MedicineStore #AntiCancer #LiverCancer
iebpharma.com/product/ibru...

Rehabilitation, follow-up care, and support from healthcare professionals and loved ones are vital in the journey toward recovery. Long-Term Monitoring.
#Ibruxen140mg #Ibrutinib #Medicine #Health #OnlineMedicine #MedicineStore #AntiCancer #LiverCancer
iebpharma.com/product/ibru...